collaborators

1 paper

stat.ME2021

A Comparison of Model-Free Phase I Dose Escalation Designs for Dual-Agent Combination Therapies

Helen Yvette Barnett, Matthew George, Donia Skanji +3

It is increasingly common for therapies in oncology to be given in combination. In some cases, patients can benefit from the interaction between two drugs, although often at the ri…